+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of Bay 12-8039, a potent new quinolone, in mouse models of typical and atypical respiratory infection



Efficacy of Bay 12-8039, a potent new quinolone, in mouse models of typical and atypical respiratory infection



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 103




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031196006

Download citation: RISBibTeXText


Related references

Comparative activity of BAY 12-8039 versus other quinolone and non-quinolone antibiotics against unrelated clinical isolates of methicillin-resistant and -susceptible Staphylococcus aureus. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 230-231, 1998

DX-619, a novel des-F -quinolone Pharmacodynamics activity and therapeutic efficacy in animal infection models. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 241, 2003

Efficacy of the novel quinolone BAY 12-8039 in the treatment of experimental endocarditis due to ciprofloxacin-susceptible and ciprofloxacin-resistant , methicillin-resistant Staphylococcus aureus. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 67, 1998

Pharmacodynamic activity of BAY 12-8039 in animal infection models. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 103, 1996

In vitro activity of Bay 12-8039, a new quinolone. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 100, 1996

Atypical rashes in adult human Parvovirus B19 infection; atypical is typical. Idcases 5: 32-33, 2016

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial. Expert Opinion on Investigational Drugs 8(2): 181-199, 2005

BAY 12-8039, a new 8-methoxy-quinolone Metabolism in rat, monkey, and man. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 103, 1996

Activity of a new quinolone, Bay 12-8039 against Chlamydia pneumoniae in vitro. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 101, 1996

Synthesis and in vitro activity of BAY 12-8039, a new 8-methoxy-quinolone. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 100, 1996

BAY 12-8039, a new 8-methoxy-quinolone Pharmacokinetics in rats and monkeys. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 103, 1996

In vitro activity of the novel quinolone Bay 12-8039 in comparison with ciprofloxacin. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 100, 1996

Studies on the phototoxic potential of a new 8-methoxy-quinolone BAY 12-8039. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 103, 1996

In vivo efficacy of J-111,225 in mouse experimental infection models including mixed infection with MRSA and P aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 247, 1998

Typical-to-atypical versus atypical-to-typical antipsychotic switching strategies and visual evoked potentials in paranoid schizophrenia. European Neuropsychopharmacology 13(Suppl. 4): S346, 2003